{
    "title": "Vaccine reagent vendor Maravai draws private equity interest-sources",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12089917/Vaccine-reagent-vendor-Maravai-draws-private-equity-sources.html",
    "date": "2023-05-16",
    "keywords": [
        "maravai",
        "market",
        "offer",
        "executive",
        "york",
        "matter",
        "thomas",
        "h",
        "technology",
        "share",
        "production",
        "ceo",
        "provider",
        "covid19",
        "pandemic",
        "equity",
        "interest",
        "firm",
        "capitalization",
        "nonbinding",
        "price",
        "certainty",
        "bid",
        "deal",
        "acquisition",
        "approach",
        "takeover",
        "target",
        "value",
        "august",
        "peak",
        "scramble",
        "reagent",
        "business",
        "anonymity",
        "spokespeople",
        "comment",
        "week",
        "revenue",
        "san",
        "company",
        "biotech",
        "slowdown",
        "success",
        "development",
        "cancer",
        "tuberculosis",
        "allcash",
        "laboratory",
        "ag",
        "time",
        "trading",
        "monday",
        "succession",
        "trey",
        "martin",
        "october",
        "breach",
        "agreement",
        "danaher",
        "involvement",
        "end",
        "july",
        "cofounder",
        "chairman",
        "hull",
        "reporting",
        "greg",
        "roumeliotis",
        "editing",
        "sen",
        "mark",
        "potter"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}